Ann E Dahlberg, MD

Ann E Dahlberg, MD

Cancer and Blood Disorders Center, Leukemia and Lymphoma Program, Pediatric Blood and Marrow Transplant Program

On staff since July 2011

Children's Title: Medical Director, Outpatient Pediatric Blood and Marrow Transplantation, Cancer and Blood Disorders Center

Academic Title: Assistant Professor, Department of Pediatrics, University of Washington School of Medicine

Research Center: Ben Towne Center for Childhood Cancer Research

"My approach to care is based on the belief that you know your child best, so your input is essential to treatment planning. I’m committed to using every tool in our toolbox in order to provide the best outcome possible. This includes relying on all data and expertise available, exploring clinical trial opportunities and making recommendations that are patient-specific and honor your child and family’s goals. "

  • Dr. Ann Dahlberg is a board-certified hematologist-oncologist who specialize in pediatric bone marrow transplantation. Dr. Dahlberg provides care for children with a variety of malignant and non-malignant diseases with a focus on patients who have leukemia.

    At Seattle Children’s, she also directs the Bone Marrow Transplantation Transition Clinic, which provides long-term follow-up care for children who have received a transplant to treat leukemia. She also is an assistant professor in the Clinical Research Division at Fred Hutchinson Cancer Center and in the Department of Pediatrics at the University of Washington School of Medicine. 

    One of the most satisfying aspects of her career has been the ability to work closely with patients in the present while striving to improve the care provided in the future. As a clinical researcher, she studies cord blood transplantation. This form of transplant involves collecting blood-forming cells, known as stem cells, from the umbilical cord after a baby’s birth. These stem cells can be used in the treatment of leukemia and other life-threatening diseases. Another primary research interest is developing strategies to reduce the risk of leukemia relapse after a transplant.

    Be the first to recommend Ann E Dahlberg, MD

Overview

Board Certification(s)

Pediatrics
Pediatric Hematology-Oncology

Medical/Professional School

Harvard Medical School, Boston, MA

Residency

University of Washington School of Medicine GME, Seattle, WA

Fellowship

University of Washington School of Medicine GME, Seattle, WA

Clinical Interests

Hematopoietic stem cell transplantation

Umbilical cord blood transplantation

Ex vivo expansion of hematopoietic stem cells

Research Description

Dr. Dahlberg is interested in cord blood transplantation and runs clinical trials in this setting. She also has an interest in developing and implementing strategies to prevent relapse after transplant in patients with leukemia.